This is a profile image of Josh Copp

Josh Copp

PartnerBay Area

Serves leaders in the medical device and medical products sectors, focusing on optimizing the portfolio while boosting R&D and commercial effectiveness

Josh advises the top teams at medical-products and device companies as they balance their portfolio and seek sources of growth. This work includes pursuing transactions, driving efficiency and effectiveness in R&D, and addressing opportunities to maximize the commercial value of core and emerging products.

Given the pressures to maintain organic growth in this sector, Josh helps executives establish a sustainable path for commercial operations, including unlocking market access and boosting commercial effectiveness. He also helps shape the business portfolio through acquisitions and R&D efficiency and effectiveness.

Examples of his recent client work include the following:

  • developing a comprehensive portfolio strategy for a durable medical-equipment manufacturer, including a spin off and supporting M&A activity that resulted in $1 billion in value creation
  • leading a commercial transformation for an orthopedic-device manufacturer, reversing a negative growth trend and resulting in a net increase in annual quarterly growth
  • conducting full due diligence of a radioactive consumable-oncology product that featured complex supply-chain requirements as well as access hurdles to new markets
  • designing a next-generation portfolio strategy for an implantable-cardiovascular-device company, architecting a product roadmap and commercial growth options supporting more than 10 percent growth

Interested in fostering cross-industry conversation, Josh has published articles addressing the dynamics that affect companies in the medical technology and device sectors. Before earning his MBA from MIT, with a focus on finance and healthcare, Josh spent 3 years working on advanced valuations and growth-strategy evaluations for the value-science team of a global consulting firm.

Published work

Accelerating growth in medtech: The next surge in portfolio moves,” McKinsey & Company, May 2022

Divestiture in medtech: Are you the natural owner of your businesses?,” McKinsey & Company, March 2019

Delivering growth: M&A in medical technology,” McKinsey & Company, January 2018

The growth imperative for medical-device companies,” McKinsey & Company, September 2017

Past Experience

Boston Consulting Group


Massachusetts Institute of Technology

Harvard University
AB, applied mathematics